Skip to main content
TipRanks
Go Ultimate75% OFF

Tali Digital (UV7) AI Stock Analysis

0 Followers
DE:UV7

Tali Digital

(Frankfurt:UV7)

Rating:―N/A
Action:N/A
Date:―

No summary available

Positive Factors
Revenue ReboundFY2026 revenue growth of about 304% shows meaningful improvement in commercial activity and product uptake from a low base. If sustained, this expanding top line can improve operating leverage and support investment in the company’s digital cognitive platform.
Negative Factors
Negative Gross ProfitNegative FY2026 gross profit indicates services were delivered below cost, while EBIT and EBITDA remained materially negative. Without improvement in unit economics, revenue growth may not translate into sustainable gross profit or provide the foundation for durable operating leverage.

Tali Digital (UV7) vs. iShares MSCI Germany ETF (EWG)

-75%-50%-25%0%25%50%75%100%DE:UV7-40.00%EWG+7.58%Dec '25Jan '26Feb '26Mar '26Apr '26May '26Jun '26Jul '26Aug '26Sep '26Oct '26Nov '26
Market Cap
EUR 5.45M
Dividend Yield
―
Average Volume (3M)
4
Price to Earnings (P/E)
-1.4
Beta (1Y)
-36.56
Revenue Growth
23541.75%
EPS Growth
-137.82%
Country
Germany
Employees
5
Sector
Healthcare
Sector Strength
51
Industry
Medical - Healthcare Information Services

Tali Digital Business Overview & Revenue Model

Company Description

TALi Digital Limited is an Australian digital health firm dedicated to improving cognitive function and behavior through its diagnostic and therapeutic offerings. The company provides TALi DETECT, an evidence-based digital screening program lasting 2...

Tali Digital Peers Comparison

Overall Rating

UnderperformOutperform
Sector (51)

Financial Indicators

DE:UV7 against its peers
NameOverall RatingMarket CapP/E RatioROEDividend YieldRevenue GrowthEPS Growth
Sector *51Neutral$7.86B-0.30-43.30%2.27%22.53%-2.21%
AU:ONEAU:ONE51NeutralAUD 113.29M-6.46-203.69%―-1.53%28.29%
AU:AHEAU:AHE43NeutralAUD 8.29M-0.42-614.15%―-46.09%70.70%
AU:BMTAU:BMT40UnderperformAUD 20.08M-1.08-58.13%―2.08%-195.31%
AU:PCKAU:PCK38UnderperformAUD 14.23M-1.57-1688.04%―11.45%0.69%
AU:ICRAU:ICR37UnderperformAUD 12.16M-5.00-416.53%―113.42%29.17%

* Healthcare Sector Average

Performance Comparison

-50%0%50%DE:UV7AU:ONEAU:BMTAU:AHEAU:ICRAU:PCKDec '25Jan '26Feb '26Mar '26Apr '26May '26Jun '26Jul '26Aug '26Sep '26Oct '26Nov '26
DE:UV7 and its peers over the selected period
Show on chartTickerCompany NamePriceChange% Change
DE:UV7Tali Digital Ltd0.03-0.02-40.00%
AU:ONEOneview Healthcare PLC Chess Depository Interests repr 10.12-0.17-58.62%
AU:BMTBeamtree Holdings Ltd0.07-0.13-66.50%
AU:AHEMedAdvisor Limited0.01-0.01-38.10%
AU:ICRInteliCare Holdings Limited0.02-0.01-39.29%
AU:PCKPainChek Ltd0.07-0.33-82.96%
Glossary
BuyA stock rated as a "Buy" is expected to perform better than the overall market or a specific benchmark over the near-to-medium term. This rating suggests the stock is likely to deliver higher returns compared to other stocks in the same sector or market index. Note: This is not investment advice; please consult a financial advisor before making investment decisions.
HoldA stock rated as a "Hold" is expected to perform in line with the overall market or a specific benchmark. This rating indicates that the stock is neither particularly compelling nor unfavorable for investment. Note: This is not investment advice; please consult a financial advisor before making investment decisions.
SellA stock rated as a "Sell" is expected to perform worse than the overall market or a specific benchmark over the near-to-medium term. This rating suggests the stock may deliver lower returns compared to other stocks in the same sector or market index. Note: This is not investment advice; please consult a financial advisor before making investment decisions.

Disclaimer

This AI Analyst Stock Report is automatically generated by our AI systems using advanced algorithms and publicly available financial, technical, and market data. While the information provided aims to be accurate and insightful, it is intended for informational purposes only and should not be considered financial advice. Any content created by an AI (Artificial Intelligence) system may contain inaccuracies and/or contain errors. Investing in stocks carries inherent risks, and past performance is not indicative of future results. This report does not account for your personal financial circumstances, objectives, or risk tolerance. Always conduct your own research or consult with a qualified financial advisor before making investment decisions. The analysis and recommendations provided are based on historical and current data and may not fully reflect future market conditions or unexpected developments. Neither the creators of this report nor its affiliated entities guarantee the accuracy, completeness, or reliability of the information presented. Use this report at your own discretion and risk.